Abstract
γ-Aminobutyric acid receptors (GABAARs) are vital for controlling excitability in the brain. This is emphasized by the numerous neuropsychiatric disorders that result from receptor dysfunction. A critical component of most native GABAARs is the α subunit. Its transmembrane domain is the target for many modulators, including endogenous brain neurosteroids that impact anxiety, stress and depression, and for therapeutic drugs, such as general anesthetics. Understanding the basis for the modulation of GABAAR function requires high-resolution structures. Here we present the first atomic structures of a GABAAR chimera at 2.8-Å resolution, including those bound with potentiating and inhibitory neurosteroids. These structures define new allosteric binding sites for these modulators that are associated with the α-subunit transmembrane domain. Our findings will enable the exploitation of neurosteroids for therapeutic drug design to regulate GABAARs in neurological disorders.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Structural insights into opposing actions of neurosteroids on GABAA receptors
Nature Communications Open Access 22 August 2023
-
Conformational transitions and allosteric modulation in a heteromeric glycine receptor
Nature Communications Open Access 13 March 2023
-
Structural basis for cannabinoid-induced potentiation of alpha1-glycine receptors in lipid nanodiscs
Nature Communications Open Access 18 August 2022
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout







References
Miller, P.S. & Smart, T.G. Binding, activation and modulation of Cys-loop receptors. Trends Pharmacol. Sci. 31, 161–174 (2010).
Corringer, P.J. et al. Structure and pharmacology of pentameric receptor channels: from bacteria to brain. Structure 20, 941–956 (2012).
Farrant, M. & Nusser, Z. Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors. Nat. Rev. Neurosci. 6, 215–229 (2005).
Braat, S. & Kooy, R.F. The GABAA receptor as a therapeutic target for neurodevelopmental disorders. Neuron 86, 1119–1130 (2015).
Rudolph, U. & Möhler, H. GABAA receptor subtypes: therapeutic potential in down syndrome, affective disorders, schizophrenia, and autism. Annu. Rev. Pharmacol. Toxicol. 54, 483–507 (2014).
Mody, I. Distinguishing between GABAA receptors responsible for tonic and phasic conductances. Neurochem. Res. 26, 907–913 (2001).
Smart, T.G. & Paoletti, P. in The Synapse (eds. Sheng, M. et al.) 191–216 (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 2012).
Jones, M.V. & Westbrook, G.L. Desensitized states prolong GABAA channel responses to brief agonist pulses. Neuron 15, 181–191 (1995).
Bright, D.P. et al. Profound desensitization by ambient GABA limits activation of δ-containing GABAA receptors during spillover. J. Neurosci. 31, 753–763 (2011).
Gielen, M., Thomas, P. & Smart, T.G. The desensitization gate of inhibitory Cys-loop receptors. Nat. Commun. 6, 6829 (2015).
Belelli, D. & Lambert, J.J. Neurosteroids: endogenous regulators of the GABAA receptor. Nat. Rev. Neurosci. 6, 565–575 (2005).
Fritschy, J.M. & Brünig, I. Formation and plasticity of GABAergic synapses: physiological mechanisms and pathophysiological implications. Pharmacol. Ther. 98, 299–323 (2003).
Picton, A.J. & Fisher, J.L. Effect of the α subunit subtype on the macroscopic kinetic properties of recombinant GABAA receptors. Brain Res. 1165, 40–49 (2007).
Hosie, A.M., Wilkins, M.E., da Silva, H.M.A. & Smart, T.G. Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites. Nature 444, 486–489 (2006).
Franks, N.P. General anaesthesia: from molecular targets to neuronal pathways of sleep and arousal. Nat. Rev. Neurosci. 9, 370–386 (2008).
Kang, J.Q. & Macdonald, R.L. Making sense of nonsense GABAA receptor mutations associated with genetic epilepsies. Trends Mol. Med. 15, 430–438 (2009).
Hilf, R.J.C. & Dutzler, R. Structure of a potentially open state of a proton-activated pentameric ligand-gated ion channel. Nature 457, 115–118 (2009).
Bocquet, N. et al. X-ray structure of a pentameric ligand-gated ion channel in an apparently open conformation. Nature 457, 111–114 (2009).
Moraga-Cid, G. et al. Allosteric and hyperekplexic mutant phenotypes investigated on an α1 glycine receptor transmembrane structure. Proc. Natl. Acad. Sci. USA 112, 2865–2870 (2015).
Wilkins, M.E., Hosie, A.M. & Smart, T.G. Identification of a β subunit TM2 residue mediating proton modulation of GABA type A receptors. J. Neurosci. 22, 5328–5333 (2002).
Nury, H. et al. X-ray structures of general anaesthetics bound to a pentameric ligand-gated ion channel. Nature 469, 428–431 (2011).
Sauguet, L. et al. Structural basis for potentiation by alcohols and anaesthetics in a ligand-gated ion channel. Nat. Commun. 4, 1697–1707 (2013).
Sauguet, L. et al. Structural basis for ion permeation mechanism in pentameric ligand-gated ion channels. EMBO J. 32, 728–741 (2013).
Fourati, Z., Sauguet, L. & Delarue, M. Genuine open form of the pentameric ligand-gated ion channel GLIC. Acta Crystallogr. D Biol. Crystallogr. 71, 454–460 (2015).
Kash, T.L., Jenkins, A., Kelley, J.C., Trudell, J.R. & Harrison, N.L. Coupling of agonist binding to channel gating in the GABAA receptor. Nature 421, 272–275 (2003).
Sigel, E., Buhr, A. & Baur, R. Role of the conserved lysine residue in the middle of the predicted extracellular loop between M2 and M3 in the GABAA receptor. J. Neurochem. 73, 1758–1764 (1999).
Hales, T.G. et al. An asymmetric contribution to gamma-aminobutyric type A receptor function of a conserved lysine within TM2-3 of alpha1, beta2, and gamma2 subunits. J. Biol. Chem. 281, 17034–17043 (2006).
Kodera, H. et al. De novo GABRA1 mutations in Ohtahara and West syndromes. Epilepsia 57, 566–573 (2016).
Hibbs, R.E. & Gouaux, E. Principles of activation and permeation in an anion-selective Cys-loop receptor. Nature 474, 54–60 (2011).
Miller, P.S. & Aricescu, A.R. Crystal structure of a human GABAA receptor. Nature 512, 270–275 (2014).
Du, J., Lü, W., Wu, S., Cheng, Y. & Gouaux, E. Glycine receptor mechanism elucidated by electron cryo-microscopy. Nature 526, 224–229 (2015).
Huang, X., Chen, H., Michelsen, K., Schneider, S. & Shaffer, P.L. Crystal structure of human glycine receptor-α3 bound to antagonist strychnine. Nature 526, 277–280 (2015).
Hénin, J., Salari, R., Murlidaran, S. & Brannigan, G. A predicted binding site for cholesterol on the GABAA receptor. Biophys. J. 106, 1938–1949 (2014).
Unwin, N. Neurotransmitter action: opening of ligand-gated ion channels. Cell 72 (Suppl.), 31–41 (1993).
Huang, X., Chen, H. & Shaffer, P.L. Crystal structures of human GlyRα3 bound to ivermectin. Structure 25, 945–950.e2 (2017).
Huang, X. et al. Crystal structures of human glycine receptor α3 bound to a novel class of analgesic potentiators. Nat. Struct. Mol. Biol. 24, 108–113 (2017).
Velisetty, P. & Chakrapani, S. Desensitization mechanism in prokaryotic ligand-gated ion channel. J. Biol. Chem. 287, 18467–18477 (2012).
Gonzalez-Gutierrez, G. & Grosman, C. Bridging the gap between structural models of nicotinic receptor superfamily ion channels and their corresponding functional states. J. Mol. Biol. 403, 693–705 (2010).
Althoff, T., Hibbs, R.E., Banerjee, S. & Gouaux, E. X-ray structures of GluCl in apo states reveal a gating mechanism of Cys-loop receptors. Nature 512, 333–337 (2014).
Mihic, S.J. et al. Sites of alcohol and volatile anaesthetic action on GABAA and glycine receptors. Nature 389, 385–389 (1997).
Howard, R.J. et al. Structural basis for alcohol modulation of a pentameric ligand-gated ion channel. Proc. Natl. Acad. Sci. USA 108, 12149–12154 (2011).
Reddy, D.S. & Rogawski, M.A. Neurosteroid replacement therapy for catamenial epilepsy. Neurotherapeutics 6, 392–401 (2009).
Bracamontes, J.R., Li, P., Akk, G. & Steinbach, J.H. A neurosteroid potentiation site can be moved among GABAA receptor subunits. J. Physiol. (Lond.) 590, 5739–5747 (2012).
Chen, Z.W. et al. Neurosteroid analog photolabeling of a site in the third transmembrane domain of the β3 subunit of the GABA(A) receptor. Mol. Pharmacol. 82, 408–419 (2012).
Hosie, A.M., Wilkins, M.E. & Smart, T.G. Neurosteroid binding sites on GABA(A) receptors. Pharmacol. Ther. 116, 7–19 (2007).
Covey, D.F. et al. Enantioselectivity of pregnanolone-induced gamma-aminobutyric acid(A) receptor modulation and anesthesia. J. Pharmacol. Exp. Ther. 293, 1009–1016 (2000).
Seljeset, S., Laverty, D. & Smart, T.G. Inhibitory neurosteroids and the GABAA receptor. Adv. Pharmacol. 72, 165–187 (2015).
Akk, G. et al. Mutations of the GABA-A receptor α1 subunit M1 domain reveal unexpected complexity for modulation by neuroactive steroids. Mol. Pharmacol. 74, 614–627 (2008).
Rüsch, D., Zhong, H. & Forman, S.A. Gating allosterism at a single class of etomidate sites on α1β2γ2L GABAA receptors accounts for both direct activation and agonist modulation. J. Biol. Chem. 279, 20982–20992 (2004).
Morales-Perez, C.L., Noviello, C.M. & Hibbs, R.E. X-ray structure of the human α4β2 nicotinic receptor. Nature 538, 411–415 (2016).
Li, G.D. et al. Identification of a GABAA receptor anesthetic binding site at subunit interfaces by photolabeling with an etomidate analog. J. Neurosci. 26, 11599–11605 (2006).
Li, G.D., Chiara, D.C., Cohen, J.B. & Olsen, R.W. Neurosteroids allosterically modulate binding of the anesthetic etomidate to γ-aminobutyric acid type A receptors. J. Biol. Chem. 284, 11771–11775 (2009).
Bocquet, N. et al. A prokaryotic proton-gated ion channel from the nicotinic acetylcholine receptor family. Nature 445, 116–119 (2007).
Winter, G., Lobley, C.M. & Prince, S.M. Decision making in xia2. Acta Crystallogr. D Biol. Crystallogr. 69, 1260–1273 (2013).
Winn, M.D. et al. Overview of the CCP4 suite and current developments. Acta Crystallogr. D Biol. Crystallogr. 67, 235–242 (2011).
McCoy, A.J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658–674 (2007).
Cowtan, K. The Buccaneer software for automated model building. 1. Tracing protein chains. Acta Crystallogr. D Biol. Crystallogr. 62, 1002–1011 (2006).
Emsley, P., Lohkamp, B., Scott, W.G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486–501 (2010).
Terwilliger, T.C. et al. Iterative model building, structure refinement and density modification with the PHENIX AutoBuild wizard. Acta Crystallogr. D Biol. Crystallogr. 64, 61–69 (2008).
Chen, V.B. et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. D Biol. Crystallogr. 66, 12–21 (2010).
Smart, O.S., Neduvelil, J.G., Wang, X., Wallace, B.A. & Sansom, M.S. HOLE: a program for the analysis of the pore dimensions of ion channel structural models. J. Mol. Graph. 14, 354–360, 376 (1996).
Pei, J. & Grishin, N.V. PROMALS3D: multiple protein sequence alignment enhanced with evolutionary and three-dimensional structural information. Methods Mol. Biol. 1079, 263–271 (2014).
Ritter, B. et al. Two WXXF-based motifs in NECAPs define the specificity of accessory protein binding to AP-1 and AP-2. EMBO J. 23, 3701–3710 (2004).
Šali, A. & Blundell, T.L. Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 234, 779–815 (1993).
Olsson, M.H.M., Søndergaard, C.R., Rostkowski, M. & Jensen, J.H. PROPKA3: consistent treatment of internal and surface residues in empirical pKa predictions. J. Chem. Theory Comput. 7, 525–537 (2011).
Trott, O. & Olson, A.J. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31, 455–461 (2010).
Miettinen, S.M. et al. NMRlipids project. The NMR Lipids Collaboration http://dx.doi.org/10.6084/m9.figshare.1585017 (2015).
Schmidt, T.H. & Kandt, C. LAMBADA and InflateGRO2: efficient membrane alignment and insertion of membrane proteins for molecular dynamics simulations. J. Chem. Inf. Model. 52, 2657–2669 (2012).
Maier, J.A. et al. ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB. J. Chem. Theory Comput. 11, 3696–3713 (2015).
Dickson, C.J. et al. Lipid14: the amber lipid force field. J. Chem. Theory Comput. 10, 865–879 (2014).
Ryckaert, J.P., Ciccotti, G. & Berendsen, H.J.C. Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J. Comput. Phys. 23, 327–341 (1977).
Darden, T., York, D. & Pedersen, L. Particle mesh Ewald: an N-log(N) method for Ewald sums in large systems. J. Chem. Phys. 98, 10089 (1993).
Acknowledgements
This work was supported by the Medical Research Council (MR/K005537/1). D.L. was in receipt of an MRC PhD studentship. O.J.A. was supported by the Carlsberg Foundation. M.G.G. was funded by the Wellcome Trust and Royal Society (104194/Z/14/Z). We thank the beamline staff at Diamond Light Source and ESRF for assistance and advice, A. Cole for technical support (crystallization, data collection and processing), P.-J. Corringer for technical advice and C. Jones for additional mutagenesis and functional electrophysiology. We also thank the Advanced Research Computing (ARC) facility, the EPSRC UK National Service for Computational Chemistry Software (NSCCS) at Imperial College London (grant no. EP/J003921/1) and the ARCHER UK National Supercomputing Services for computer time granted via the UK High-End Computing Consortium for Biomolecular Simulation, HECBioSim (http://www.hecbiosim.ac.uk), supported by EPSRC (grant no. EP/L000253/1).
Author information
Authors and Affiliations
Contributions
D.L. and T.G.S. jointly planned the project, performed data analyses and wrote the manuscript. D.L. generated the receptor constructs, optimized receptor expression, purification and crystallization, carried out structure solution and model building (assisted by M.G.G. with structural analysis). D.L. and P.T. performed electrophysiology experiments. M.F. carried out site-directed mutagenesis. T.G.S. performed the kinetic modeling. O.J.A. and P.C.B. performed the molecular dynamics simulations and docking. M.G. helped plan and design desensitization experiments. All authors contributed towards editing the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–8 and Supplementary Notes 1,2 (PDF 2475 kb)
Rights and permissions
About this article
Cite this article
Laverty, D., Thomas, P., Field, M. et al. Crystal structures of a GABAA-receptor chimera reveal new endogenous neurosteroid-binding sites. Nat Struct Mol Biol 24, 977–985 (2017). https://doi.org/10.1038/nsmb.3477
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nsmb.3477
This article is cited by
-
Conformational transitions and allosteric modulation in a heteromeric glycine receptor
Nature Communications (2023)
-
Structural insights into opposing actions of neurosteroids on GABAA receptors
Nature Communications (2023)
-
Structural basis for cannabinoid-induced potentiation of alpha1-glycine receptors in lipid nanodiscs
Nature Communications (2022)
-
β subunits of GABAA receptors form proton-gated chloride channels: Insights into the molecular basis
Communications Biology (2022)
-
The interaction of steroids with phospholipid bilayers and membranes
Biophysical Reviews (2022)